The indictments allege that, using pharmacies in Michigan and Ohio, the defendants — who are all licensed pharmacists and/or owners of the pharmacies —billed Medicare, Medicaid and Blue Cross Blue Shield for prescription drugs that were neither purchased nor dispensed.
The defendants also are accused of billing Medicare and Medicaid for drugs that were often medically unnecessary and for billing for medicines they claimed to have dispensed to patients after their dates of death.
The defendants allegedly received more than $12.1 million from Medicare, Medicaid and Blue Cross Blue Shield from the fraudulent claims. The scheme allegedly took place from 2010 to 2019.
The nine pharmacists are charged with healthcare fraud, conspiracy to commit healthcare fraud and wire fraud.
Read the U.S. Justice Department’s full news release here.
More articles on pharmacy:
New CMS rule promotes payer drug price negotiations based on clinical outcomes
10 things to know about the steroid called a ‘major breakthrough’ in COVID-19 treatment
WHO drops hydroxychloroquine from coronavirus trial after studies suggest inefficacy
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.